telehealth glp-1 crackdown news FDA issued 25 warning letters to companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Issues Warnings to 30

Made in FDA-registered, NSF-certified, cGMP-compliant facilities

57 In addition, the phagocytic activity of macrophages exposed to BCKA is inhibited

While Wegovy can cause gastrointestinal side effects like nausea, vomiting, and diarrhea, gradually increasing the dose with the guidance of a healthcare professional can help reduce these effects

Clinical utility of cardiovascular risk scores for identification of people with type 2 diabetes more likely to benefit from either GLP-1 receptor agonist or SGLT2 inhibitor therapy

The 'central planning' mechanism of GLP-1: from molecular signaling to systemic regulation GLP-1 is an incretin secreted by intestinal L cells, and its bioactive forms (GLP-1 (7-37) and GLP-1 (7-36) amide) have a half-life of only 2.1-2.4 minutes